Lorenzo De Benedictis
Company: 3CON Technologies
Job title: Head of Business Unit, Pharma and Medical
Seminars:
Advancement in mRNA Therapeutics and Vaccines: Overcoming RNase-Related Challenges through RNase-free Single-Use Assemblies & Non-Thermal Plasma-based Inhibition 1:00 pm
Pioneering Non-Thermal Plasma inhibition of RNases as a cutting-edge alternative for ensuring RNase-free single-use bioprocess containers and assemblies, when conventional methods like thermal, irradiation and chemical inactivation fail Elevate mRNA development and manufacturing processes by mitigating the risk of RNase contamination Exploring the inhibition of RNase through ionized air targeted at enzymes, showcasing an innovative…Read more
day: Day Two